STOCK TITAN

[SCHEDULE 13G/A] Moderna, Inc. Amended Passive Investment Disclosure

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

FMR LLC and Abigail P. Johnson have filed Amendment No. 1 to a Schedule 13G reporting a significant stake in Moderna Inc. common stock. As of the 01/30/2026 event date, they beneficially own 41,301,468.88 shares, representing 10.6% of Moderna’s outstanding common stock.

FMR LLC reports sole voting power over 41,192,005.42 shares and sole dispositive power over 41,301,468.88 shares. Abigail P. Johnson reports sole dispositive power over 41,301,468.88 shares and no voting power. The securities are stated to be held in the ordinary course of business and not for the purpose of changing or influencing control of Moderna. One or more other persons may receive dividends or sale proceeds from these shares, but no such person has more than 5% of the class.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



FMR LLC
Signature:Stephanie J. Brown
Name/Title:Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries*
Date:02/05/2026
Abigail P. Johnson
Signature:Stephanie J. Brown
Name/Title:Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson**
Date:02/05/2026

Comments accompanying signature: * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. ** This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 31, 2023, accession number: 0000315066-23-000038.
Exhibit Information

Please see Exhibit 99 for 13d-1(k) (1) agreement.